Maine CDC Information
- Health Topics A-Z
- Conferences & Events
- Data and Reports
- Maine CDC Rules
- Public Health Training
- State Health Improvement Plan
- About Us
District Public Health
- Local Health Officers
- Local Public Health Districts
- Public Health Emergency Preparedness
- Statewide Coordinating Council
Information for Health Care Providers
Maine CDC Health Advisory
October 24, 2023
Limited Availability of Nirsevimab in the United States
The U.S. Centers for Disease Control and Prevention (U.S. CDC) is issuing this Health Alert Network (HAN) Health Advisory to provide options for clinicians to protect infants from respiratory syncytial virus (RSV) in the context of a limited supply of nirsevimab, a long-acting monoclonal antibody immunization product recommended for preventing RSV-associated lower respiratory tract disease in infants.
